R&D Data-driven disease research harnessing the genome Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.
R&D Bioanalytical labs need to reimagine data to streamline thei... The fundamental questions in the trial phases of drug development are “Does it work?”, “Is it safe?”, and “What else do we need to know?”
Digital To fight rare diseases, win the data battle first Innovation is the key to evolution. In the pharmaceutical space, brilliant advancements have occurred with drugs with large population pools.
Sales & Marketing Veeva Commercial Summit '23: The power of connectivity Veeva Systems’ Commercial Summit returned to Madrid for 2023, with over 1,500 life sciences industry professionals in attendance.
Digital Retaining the human element of AI within pharma and healthca... Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Digital What AI really means for biology and the pharmaceutical indu... A blanket statement like ’We need to use AI’ today is just as futile as saying ’We need to use electricity’ during the second industrial revolution.
News NHS to offer Wegovy to a million more people in England The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
